| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2025 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Aug 31, 2025 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2025 | Active | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Mar 31, 2025 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Mar 31, 2025 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| LEAD AND COPPER RULE REVISIONS | Monitoring | N/A | N/A | Jan 31, 2025 | Active | N/A |
| LEAD AND COPPER RULE REVISIONS | Health-Based | N/A | N/A | Jan 31, 2025 | Active | N/A |
| LEAD AND COPPER RULE REVISIONS | Health-Based | N/A | N/A | Jan 31, 2025 | Active | N/A |
| LEAD AND COPPER RULE REVISIONS | Monitoring | N/A | N/A | Jan 31, 2025 | Active | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2024 | Active | N/A |
| TTHM | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| TTHM | Health-Based | N/A | 86.4733 | Dec 31, 2024 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Health-Based | N/A | 89.19 | Dec 31, 2024 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Dec 31, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2024 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Nov 30, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2024 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Oct 31, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Total Haloacetic Acids (HAA5) | Health-Based | N/A | 71.5925 | Sep 30, 2024 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Sep 30, 2024 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Sep 30, 2024 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Sep 30, 2024 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Sep 30, 2024 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Health-Based | N/A | 62.1675 | Jun 30, 2024 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Jun 30, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Jun 30, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | May 31, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2024 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Mar 31, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Sep 30, 2023 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Aug 31, 2023 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2023 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Jun 30, 2023 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Active | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Active | N/A |
| E. COLI | Monitoring | 0 | N/A | Dec 31, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Health-Based | N/A | 63 | Sep 30, 2022 | Resolved | N/A |
| TTHM | Health-Based | N/A | 97.15 | Sep 30, 2022 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Sep 30, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Health-Based | N/A | 63.8367 | Sep 30, 2022 | Resolved | N/A |
| TTHM | Health-Based | N/A | 141.05 | Jun 30, 2022 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Health-Based | N/A | 97.075 | Jun 30, 2022 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Health-Based | N/A | 60.9 | Jun 30, 2022 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Jun 30, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Jun 30, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Jun 30, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Jun 30, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Jun 30, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Jun 30, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Jun 30, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Jun 30, 2022 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| TTHM | Health-Based | N/A | 177.25 | Mar 31, 2022 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Health-Based | N/A | 120.15 | Mar 31, 2022 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Health-Based | N/A | 70.0333 | Mar 31, 2022 | Resolved | N/A |
| TTHM | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Health-Based | N/A | 114.5 | Dec 31, 2021 | Resolved | N/A |
| TTHM | Health-Based | N/A | 170.75 | Dec 31, 2021 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Asbestos | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| TTHM | Health-Based | N/A | 156.5 | Sep 30, 2021 | Resolved | N/A |
| TTHM | Health-Based | N/A | 156.5 | Sep 30, 2021 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Health-Based | N/A | 114.425 | Sep 30, 2021 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Health-Based | N/A | 114.425 | Sep 30, 2021 | Resolved | N/A |
| TTHM | Health-Based | N/A | 141.73 | Jun 30, 2021 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Health-Based | N/A | 78.3 | Jun 30, 2021 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Health-Based | N/A | 78.3 | Jun 30, 2021 | Resolved | N/A |
| TTHM | Health-Based | N/A | 141.73 | Jun 30, 2021 | Resolved | N/A |
| TTHM | Health-Based | N/A | 141.73 | Jun 30, 2021 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | May 31, 2021 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | May 31, 2021 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2021 | Resolved | N/A |
| TTHM | Health-Based | N/A | 120.15 | Mar 31, 2021 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Health-Based | N/A | 63.075 | Mar 31, 2021 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Health-Based | N/A | 63.075 | Mar 31, 2021 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Health-Based | N/A | 63.075 | Mar 31, 2021 | Resolved | N/A |
| Total Haloacetic Acids (HAA5) | Health-Based | N/A | 63.075 | Mar 31, 2021 | Resolved | N/A |
| TTHM | Health-Based | N/A | 120.15 | Mar 31, 2021 | Resolved | N/A |
| TTHM | Health-Based | N/A | 120.15 | Mar 31, 2021 | Resolved | N/A |
| TTHM | Health-Based | N/A | 120.15 | Mar 31, 2021 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Mar 31, 2021 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Mar 31, 2021 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |